Giiant Pharma
Latest round
- Seed
Last raised
- Jun 2021
Total raised
- $12M
Investors
- 7
About Giiant Pharma
Based in Canada, Giiant Pharma Inc., founded in 2014 and headquartered in Montreal, Canada, focuses on gut-restricted therapies for inflammatory bowel diseases.Giiant Pharma specializes in the development of gut-restricted, small molecule, tissue-specific drug therapeutics specifically designed for the treatment of inflammatory bowel diseases (IBD). Their core product offerings leverage an innovative Gastrointestinal-Induced Anti-inflammatory technology that utilizes the gut microbiota's bacterial activity to bioactivate and release active drug substances at targeted sites within the lower gastrointestinal tract. This precision delivery method ensures limited systemic absorption, thereby enhancing safety and local efficacy, which is critical for patients dealing with chronic conditions like IBD. The company’s products are primarily aimed at healthcare providers and specialty pharmacies within North America and Europe, focusing on improving the quality of life for patients suffering from IBD.Giiant Pharma generates revenue through strategic partnerships with healthcare providers and specialty pharmacies that facilitate the distribution of their proprietary therapeutic products. The transaction structure typically involves B2B agreements where Giiant Pharma collaborates with healthcare institutions to provide their drug candidates, ensuring targeted therapeutic delivery to patients. Pricing plans for their flagship products reflect the specialized nature of their therapies, which are designed to address specific gastrointestinal conditions while minimizing side effects. The company's approach to revenue generation emphasizes a partnership model, fostering long-term relationships with institutions that serve the IBD patient population.In January 2023, Giiant Pharma Inc. The company aims to expand its product offerings and enhance its presence in targeted markets across North America and Europe, with plans to launch new therapeutics that address the complexities of inflammatory bowel diseases.
Who invested in Giiant Pharma
7 investors across 2 rounds
See all investors in Giiant Pharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Giiant Pharma
Who invested in Giiant Pharma?
Giiant Pharma has 7 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Giiant Pharma raised?
Giiant Pharma has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Giiant Pharma last raise money?
Giiant Pharma's most recent round on record is a Seed, in Jun 2021.
What does Giiant Pharma do?
Based in Canada, Giiant Pharma Inc.
Where is Giiant Pharma headquartered?
Giiant Pharma is headquartered in Montreal, Canada.
Which VCs invest in companies like Giiant Pharma?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Giiant Pharma's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Giiant Pharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.